233 related articles for article (PubMed ID: 26896440)
21.
Durkin J; Poe AR; Belfer SJ; Rodriguez A; Tang SH; Walker JA; Kayser MS
Neurobiol Sleep Circadian Rhythms; 2023 Nov; 15():100101. PubMed ID: 37593040
[TBL] [Abstract][Full Text] [Related]
22. Neurofibromin 1 mediates sleep depth in Drosophila.
Brown EB; Zhang J; Lloyd E; Lanzon E; Botero V; Tomchik S; Keene AC
PLoS Genet; 2023 Dec; 19(12):e1011049. PubMed ID: 38091360
[TBL] [Abstract][Full Text] [Related]
23. Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.
van der Vaart T; van Woerden GM; Elgersma Y; de Zeeuw CI; Schonewille M
Genes Brain Behav; 2011 Jun; 10(4):404-9. PubMed ID: 21352477
[TBL] [Abstract][Full Text] [Related]
24. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
25. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
[TBL] [Abstract][Full Text] [Related]
26. Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin.
Welti S; Kühn S; D'Angelo I; Brügger B; Kaufmann D; Scheffzek K
Hum Mutat; 2011 Feb; 32(2):191-7. PubMed ID: 21089070
[TBL] [Abstract][Full Text] [Related]
27. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.
Ismat FA; Xu J; Lu MM; Epstein JA
J Clin Invest; 2006 Sep; 116(9):2378-84. PubMed ID: 16906226
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
Abramowicz A; Gos M
Dev Period Med; 2014; 18(3):297-306. PubMed ID: 25182393
[TBL] [Abstract][Full Text] [Related]
30. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
[TBL] [Abstract][Full Text] [Related]
32. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.
Yu X; Chen S; Potter OL; Murthy SM; Li J; Pulcini JM; Ohashi N; Winata T; Everett ET; Ingram D; Clapp WD; Hock JM
Bone; 2005 May; 36(5):793-802. PubMed ID: 15804420
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.
Arun V; Worrell L; Wiley JC; Kaplan DR; Guha A
FEBS Lett; 2013 May; 587(10):1466-73. PubMed ID: 23583712
[TBL] [Abstract][Full Text] [Related]
34. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.
Kuorilehto T; Nissinen M; Koivunen J; Benson MD; Peltonen J
J Bone Miner Res; 2004 Jun; 19(6):983-9. PubMed ID: 15125795
[TBL] [Abstract][Full Text] [Related]
35. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
36. Motor deficits and neurofibromatosis type 1 (NF1)-associated MRI impairments in a mouse model of NF1.
Robinson A; Kloog Y; Stein R; Assaf Y
NMR Biomed; 2010 Dec; 23(10):1173-80. PubMed ID: 20586111
[TBL] [Abstract][Full Text] [Related]
37. Neurofibromin signaling and synapses.
Hsueh YP
J Biomed Sci; 2007 Jul; 14(4):461-6. PubMed ID: 17370141
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.
Li F; Munchhof AM; White HA; Mead LE; Krier TR; Fenoglio A; Chen S; Wu X; Cai S; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1921-30. PubMed ID: 16644864
[TBL] [Abstract][Full Text] [Related]
39. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
[TBL] [Abstract][Full Text] [Related]
40. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
